AERI

Aerie Pharmaceuticals, Inc.

NASDAQHealthcareDrug Manufacturers - Specialty & GenericUS

USD15.25

+0.00 (+0.00%)

CEO

Vicente Anido

IPO Date

2013-10-25

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Exchange

NASDAQ

Country

Open

$15.24

Prev. Close

$15.25

Day Low

$15.24

Day High

$15.25

52W Low

$4.81

52W High

$15.37

Volume

1.22M

News SentimentBullish

Articles

Avg Positive

31.5%

Avg Negative

12.9%

Avg Neutral

55.5%

News Feed

Aerie Pharmaceuticals Announces Appointment of Leon J. Atencia, Director of Regulatory Affairs

Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference – UPDATED RELEASE

Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan